Does subclinical hypothyroidism and/or thyroid autoimmunity influence the IVF/ICSI outcome? Review of the literature

Research output

Abstract

While overt hypothyroidism is a well-known risk factor for infertility, the association of subclinical hypothyroidism (SCH) or thyroid autoimmunity and reproductive failure has been still not elucidated. In this literature review, the current data on the effect of SCH and/or thyroid autoimmunity and human reproduction is presented. The main ART outcome measures are as follows: number of oocytes retrieved, fertilization rate, implantation rate, clinical pregnancy rate per embryo transfer, embryo quality, miscarriage rate, and live birth rate. Current guidelines on the management of women with SCH and/or thyroid autoimmunity undergoing ART cycles will be presented in this review.
Original languageEnglish
Pages (from-to)56-59
JournalGynecological Endocrinology
Volume35
Issue numbersup1
DOIs
Publication statusE-pub ahead of print - 18 Sep 2019

Fingerprint

Intracytoplasmic Sperm Injections
Hypothyroidism
Autoimmunity
Thyroid Gland
Birth Rate
Embryo Transfer
Live Birth
Spontaneous Abortion
Pregnancy Rate
Fertilization
Infertility
Oocytes
Reproduction
Embryonic Structures
Outcome Assessment (Health Care)
Guidelines

Scopus subject areas

  • Medicine(all)

Cite this

@article{ad31984fbb7b4a188359ee94cb72ceb1,
title = "Does subclinical hypothyroidism and/or thyroid autoimmunity influence the IVF/ICSI outcome? Review of the literature",
abstract = "While overt hypothyroidism is a well-known risk factor for infertility, the association of subclinical hypothyroidism (SCH) or thyroid autoimmunity and reproductive failure has been still not elucidated. In this literature review, the current data on the effect of SCH and/or thyroid autoimmunity and human reproduction is presented. The main ART outcome measures are as follows: number of oocytes retrieved, fertilization rate, implantation rate, clinical pregnancy rate per embryo transfer, embryo quality, miscarriage rate, and live birth rate. Current guidelines on the management of women with SCH and/or thyroid autoimmunity undergoing ART cycles will be presented in this review.",
author = "Safarian, {Galina Khachikovna} and Gzgzyan, {Alexander Mkrtichevich} and Dzhemlikhanova, {Lyailya Kharryasovna} and Niauri, {Dariko Alexandrovna}",
year = "2019",
month = "9",
day = "18",
doi = "10.1080/09513590.2019.1653564",
language = "English",
volume = "35",
pages = "56--59",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Taylor & Francis",
number = "sup1",

}

TY - JOUR

T1 - Does subclinical hypothyroidism and/or thyroid autoimmunity influence the IVF/ICSI outcome? Review of the literature

AU - Safarian, Galina Khachikovna

AU - Gzgzyan, Alexander Mkrtichevich

AU - Dzhemlikhanova, Lyailya Kharryasovna

AU - Niauri, Dariko Alexandrovna

PY - 2019/9/18

Y1 - 2019/9/18

N2 - While overt hypothyroidism is a well-known risk factor for infertility, the association of subclinical hypothyroidism (SCH) or thyroid autoimmunity and reproductive failure has been still not elucidated. In this literature review, the current data on the effect of SCH and/or thyroid autoimmunity and human reproduction is presented. The main ART outcome measures are as follows: number of oocytes retrieved, fertilization rate, implantation rate, clinical pregnancy rate per embryo transfer, embryo quality, miscarriage rate, and live birth rate. Current guidelines on the management of women with SCH and/or thyroid autoimmunity undergoing ART cycles will be presented in this review.

AB - While overt hypothyroidism is a well-known risk factor for infertility, the association of subclinical hypothyroidism (SCH) or thyroid autoimmunity and reproductive failure has been still not elucidated. In this literature review, the current data on the effect of SCH and/or thyroid autoimmunity and human reproduction is presented. The main ART outcome measures are as follows: number of oocytes retrieved, fertilization rate, implantation rate, clinical pregnancy rate per embryo transfer, embryo quality, miscarriage rate, and live birth rate. Current guidelines on the management of women with SCH and/or thyroid autoimmunity undergoing ART cycles will be presented in this review.

UR - https://www.tandfonline.com/doi/abs/10.1080/09513590.2019.1653564?journalCode=igye20

U2 - 10.1080/09513590.2019.1653564

DO - 10.1080/09513590.2019.1653564

M3 - Article

VL - 35

SP - 56

EP - 59

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - sup1

ER -